CompanyNasdaqSan Diego, CA

Bionano Genomics, Inc

Bionano develops optical genome mapping (OGM) solutions and genome analysis software for research and clinical applications.

SEC EDGAR ClinicalTrials.gov

10-QNov 10Latest SEC filing

Form DJul 10$20M sold

November 2026

Bionano reports Q3 2026 revenue up 12% on reimbursement and publication progress

Nov 10Quarterly updateBionano Genomics, Inc

October 2026

Bionano Genomics files S-1 to register 1.3 million warrant shares

Oct 27FinancingBionano Genomics, Inc